Saphnelo

High magnification micrograph of diffuse proliferative lupus nephritis

Marketing

Off-label drugs fall out of favor in lupus

New biologics in the form of GSK’s Benlysta and AstraZeneca’s Saphnelo have nearly doubled in use for systemic lupus erythematosus since 2021.

Ben Adams Jun 16, 2023 10:16am

AstraZeneca rolls out Here for More campaign for lupus drug Saphnelo

AZ rolls out first DTC campaign for lupus drug Saphnelo

May 11, 2022 4:47pm

AstraZeneca blog cover for lupus patients after Saphnelo approval

AstraZeneca preps new lupus launch with patient-designed support

Aug 2, 2021 4:00pm

Saphnelo

AstraZeneca's Saphnelo to challenge GSK's Benlysta in lupus

Aug 2, 2021 9:00am